BBLGW vs. ADMA

Last updated Jun 23, 2026

BBLGW (Bone Biologics Corp Warrants) and ADMA (ADMA Biologics, Inc.) are both stocks. Both are in the Healthcare sector — BBLGW in Medical Devices, ADMA in Biotechnology. Over the past 3 years, BBLGW returned 69.08%/yr vs 30.34%/yr for ADMA. At a 0.01 correlation, their price movements are largely independent.

Performance

BBLGW vs. ADMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bone Biologics Corp Warrants (BBLGW) and ADMA Biologics, Inc. (ADMA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBLGW achieves a -6.45% return, which is significantly higher than ADMA's -53.02% return.

BBLGW

• 1D: 16.47%
• 1M: -11.80%
• YTD: -6.45%
• 6M: -34.09%
• 1Y: -3.33%
• 3Y*: 69.08%
• 5Y*: —
• 10Y*: —

ADMA

• 1D: 3.13%
• 1M: 4.00%
• YTD: -53.02%
• 6M: -56.89%
• 1Y: -51.69%
• 3Y*: 30.34%
• 5Y*: 38.86%
• 10Y*: 2.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBLGW vs. ADMA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
BBLGW Bone Biologics Corp Warrants	-6.45%	-61.25%	920.41%	638.23%	-97.47%	-17.84%
ADMA ADMA Biologics, Inc.	-53.02%	6.36%	279.42%	16.49%	175.18%	25.89%

Correlation

The correlation between BBLGW and ADMA is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.09
Correlation (3Y) Calculated over the trailing 3-year period	-0.01
Correlation (All Time) Calculated using the full available price history since Oct 13, 2021	0.01

Fundamentals

Market Cap BBLGW : $26.03M ADMA : $2.06B
EPS BBLGW : -$2.15 ADMA : $0.68
PB Ratio BBLGW : 5.57 ADMA : 5.27
Total Revenue (TTM) BBLGW : $0.00 ADMA : $509.86M
Gross Profit (TTM) BBLGW : $0.00 ADMA : $312.42M
EBITDA (TTM) BBLGW : -$2.90M ADMA : $218.74M

Return for Risk

BBLGW vs. ADMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBLGW

BBLGW Risk / Return Rank: 50
BBLGW Sharpe Ratio Rank: 41
BBLGW Sortino Ratio Rank: 54
BBLGW Omega Ratio Rank: 75
BBLGW Calmar Ratio Rank: 40
BBLGW Martin Ratio Rank: 40

ADMA

ADMA Risk / Return Rank: 7
ADMA Sharpe Ratio Rank: 6
ADMA Sortino Ratio Rank: 8
ADMA Omega Ratio Rank: 7
ADMA Calmar Ratio Rank: 10
ADMA Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBLGW vs. ADMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bone Biologics Corp Warrants (BBLGW) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BBLGW	ADMA	Difference
Sharpe ratio: Return per unit of total volatility	-0.03	-0.96	+0.93
Sortino ratio: Return per unit of downside risk	0.95	-1.32	+2.27
Omega ratio: Gain probability vs. loss probability	1.25	0.82	+0.43
Calmar ratio: Return relative to maximum drawdown	-0.05	-0.83	+0.78
Martin ratio: Return relative to average drawdown	-0.11	-1.66	+1.55

BBLGW vs. ADMA - Sharpe Ratio Comparison

The current BBLGW Sharpe Ratio is -0.03, which is higher than the ADMA Sharpe Ratio of -0.96. The chart below compares the historical Sharpe Ratios of BBLGW and ADMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BBLGW vs. ADMA - Drawdown Comparison

The maximum BBLGW drawdown since its inception was -98.80%, which is greater than ADMA's maximum drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for BBLGW and ADMA.

Drawdown Indicators

	BBLGW	ADMA	Difference
Max Drawdown Largest peak-to-trough decline	-98.80%	-91.28%	-7.52%
Max Drawdown (1Y) Largest decline over 1 year	-66.62%	-62.71%	-3.91%
Max Drawdown (3Y) Largest decline over 3 years	-96.92%	-68.99%	-27.93%
Max Drawdown (5Y) Largest decline over 5 years	—	-68.99%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-86.11%	—
Current Drawdown Current decline from peak	-84.74%	-65.03%	-19.71%
Average Drawdown Average peak-to-trough decline	-70.94%	-53.07%	-17.87%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.71%	31.23%	+0.48%

Volatility

BBLGW vs. ADMA - Volatility Comparison

Bone Biologics Corp Warrants (BBLGW) has a higher volatility of 44.84% compared to ADMA Biologics, Inc. (ADMA) at 10.25%. This indicates that BBLGW's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBLGW	ADMA	Difference
Volatility (1M) Calculated over the trailing 1-month period	44.84%	10.25%	+34.59%
Volatility (6M) Calculated over the trailing 6-month period	118.61%	45.72%	+72.89%
Volatility (1Y) Calculated over the trailing 1-year period	130.13%	54.23%	+75.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	251.31%	59.49%	+191.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	251.31%	69.07%	+182.24%

Dividends

BBLGW vs. ADMA - Dividend Comparison

Neither BBLGW nor ADMA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both BBLGW and ADMA in my portfolio?

BBLGW and ADMA have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBLGW or ADMA?

BBLGW has higher volatility (44.84%) compared to ADMA (10.25%). In terms of maximum drawdown, BBLGW dropped -98.80% vs ADMA's -91.28%.

Which has better risk-adjusted returns?

BBLGW currently has the higher Sharpe Ratio (-0.03 vs -0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.